Related by context. All words. (Click for frequent words.) 78 initiate Phase 2b 76 initiate Phase Ib 71 Phase IIIb clinical 71 initiate multicenter 71 Phase Ib II 70 phase IIb 70 phase IIa clinical 69 phase IIa 69 initiate Phase 2a 69 Phase IIb trials 68 BLA filing 68 initiate Phase 1b 68 initiated Phase Ib 68 initiate Phase 68 phase IIb trial 67 SUCCEED trial 67 Phase Ib clinical 67 initiate Phase IIa 67 Phase IIa trial 67 Phase IIb clinical trials 67 Phase Ib study 67 phase Ib 66 Phase 2a clinical 66 forodesine 66 randomized Phase 2b 66 Phase 1b trial 66 APEX PD 66 Phase Ib 66 Phase 1a clinical 66 elotuzumab 66 pivotal bioequivalence 66 Corlux 66 MOZOBIL 66 Phase 2b clinical 66 Phase 2a trial 66 Phase #b/#a 66 compound INCB# 66 confirmatory Phase III 66 CRMD# 66 multicenter Phase II 66 tramiprosate Alzhemed TM 65 PRECISE Trial 65 IIa trial 65 Phase IIb clinical 65 SinuNase ™ 65 Initiate Phase 65 ACCLAIM II 65 Phase IIb trial 65 Phase 2b study 65 oral ridaforolimus 65 GALNS 65 Cimzia TM 65 Phase 1b clinical 65 rALLy clinical trial 65 PANVAC VF 65 TAXUS Element Stent System 65 Phase 1b 65 AIMM trial 64 Androxal TM 64 PRECISE trial 64 Phase 2b trial 64 alvespimycin 64 Alzhemed TM 64 midstage clinical 64 deforolimus 64 TEMSO 64 Phase 2a 64 Phase IIB 64 multicenter Phase 64 Phase 1a 64 phase IIb study 64 Phase #b/#a clinical 64 IIb clinical trial 64 Phase 1b clinical trials 64 phase IIb clinical 64 IIa clinical 64 Phase III clinical 64 Phase IIb 64 phase Ib clinical 64 budesonide foam 64 seliciclib CYC# 64 confirmatory pivotal 64 FOLOTYN ® 64 phase IIb III 64 Phase IIb III 64 phase 2a 63 Surfaxin LS 63 registrational 63 oral methylnaltrexone 63 Zenvia ™ 63 Phase 2b clinical trials 63 apricitabine ATC 63 Canvaxin 63 Tramiprosate ALZHEMED TM 63 TOCOSOL Paclitaxel 63 IND submission 63 GetGoal Phase III 63 RSD# oral 63 Sular formulation 63 vidofludimus 63 Initiates Phase II 63 brivaracetam 63 initiate multicenter Phase 63 oral deforolimus 63 HGS# 63 Allovectin 7 R 63 alemtuzumab Campath 63 pivotal Phase III 63 confirmatory Phase 3 63 Initiates Enrollment 63 Phase 2b kidney transplant 63 Phase Ib IIa 63 GLP toxicology studies 63 ulimorelin 63 Oglemilast 63 MEND CABG II 63 Phase IIa clinical 62 Initiates Phase III 62 CLIRS trial 62 Allovectin 7 62 Archexin 62 Harry Palmin President 62 Begins Dosing 62 ADVANCE PD 62 ruxolitinib 62 MEND CABG 62 pharmacokinetic PK study 62 INCB# [001] 62 Phase III 62 oral picoplatin 62 Phase 2a clinical trials 62 Plicera 62 develop GED aPC 62 nalbuphine ER 62 prodrug stimulant 62 PREOS R 62 IIa trials 62 Tocosol Paclitaxel 62 glucokinase activator 62 Phase IIa 62 Completes Patient Enrollment 62 torezolid phosphate 62 PF # [002] 62 Annamycin 62 Aflibercept 62 Quinamed 62 mertansine 62 KRYSTEXXA TM pegloticase 62 ENDEAVOR III 62 Dyloject TM 62 YONDELIS 62 acyclovir Lauriad R 62 SNS# T 62 multicenter phase 62 evaluating satraplatin 62 ANTEGREN 62 Phase II 62 ONCONASE R 62 CAMPATH 62 Insegia 62 rasagiline tablets 62 Tezampanel 62 bevirimat Study 62 evaluating mipomersen 62 Phase lll 62 Phase III HEAT 62 virus HCV protease inhibitor 62 RE SURGE 62 Zybrestat 62 lomitapide 62 Gattex 61 Phase IIa trials 61 Zemplar Capsules 61 JAK inhibitor 61 DPX Survivac 61 oral salmon calcitonin 61 markets HP Acthar 61 LEVADEX ™ 61 dose escalation Phase 61 PDE4 inhibitor 61 Bicifadine 61 NDA resubmission 61 OMNARIS Nasal Spray 61 Phase III Pivotal 61 Personalized Immunotherapy 61 Dacogen injection 61 midstage trials 61 dirucotide 61 Phase III pivotal 61 Biopharmaceuticals AG 61 Pivotal Phase III 61 tiapamil 61 Auxilium Pharma 61 Phase Ia 61 BRIM2 61 Telatinib 61 T Pred 61 Zenvia Phase III 61 lintuzumab SGN 61 registrational trial 61 TBC# 61 Sigma Tau SpA 61 balsalazide tablet 61 Sanctura XR 61 LymphoStat B TM 61 compound KOS 61 INSPIRE Trial Phase III 61 REVIVE Diabetes 61 NYSE Amex PTN 61 cathepsin K inhibitor 61 Panzem R NCD 61 lucinactant 61 evaluating tivozanib 61 BCX# 61 Proellex TM 61 CB2 selective receptor agonist 61 Phase IIIb 61 cannabinor 61 enzastaurin 61 ongoing Phase 1b 61 FDA approvable letter 61 MAA submission 61 Phase III multicenter 61 dose escalation clinical 61 SPARLON 61 oral prodrug 61 Phase III ThermoDox 61 NEBIDO 61 ENDEAVOR IV 61 PEG PAL 61 JZP 61 Degarelix 61 zileuton IV 61 Troxatyl 61 CHAMPION PCI 61 PHX# 61 trastuzumab DM1 T DM1 61 IMC #B 61 ITAX 61 PSMA ADC 61 ongoing Phase IIIb 61 Urocidin 61 investigational immunotherapy 60 VitiGam 60 OncoVex 60 tolevamer 60 NO# [002] 60 PEG SN# 60 ASX UNS 60 Ixempra 60 OncoGel 60 Fodosine 60 Phase #/#a trial 60 Omacetaxine 60 MAGE A3 ASCI 60 Evoltra TM 60 Phase III LibiGel 60 rALLy trial 60 Memryte 60 Uvidem 60 neratinib 60 Phase III ADT 60 Empatic ™ 60 Nasdaq NPSP announced 60 AZD# TC 60 budesonide MMX Phase III 60 FORTIS M trial 60 placebo controlled clinical 60 Amoxicillin PULSYS Phase III 60 investigational humanized monoclonal antibody 60 Kamada AAT 60 ritonavir boosted danoprevir 60 Dr. Fahar Merchant 60 Saforis 60 Ocrelizumab 60 Acetavance TM intravenous acetaminophen 60 OLpur TM H2H 60 octreotide implant 60 Diamyd ® 60 Velcade bortezomib 60 trastuzumab DM1 60 next generation URAT1 60 Presents Preclinical 60 Cutanea Life Sciences 60 Bayer HealthCare Onyx Pharmaceuticals 60 Viramidine 60 non nucleoside inhibitor 60 generation PNP inhibitor 60 adecatumumab MT# 60 Ozarelix 60 metastatic hormone refractory 60 SUTENT ® 60 ENRICH trial 60 dose escalation trial 60 bardoxolone 60 Sulonex TM 60 Valtropin 60 IMA# 60 SPRYCEL ® 60 Files Investigational 60 HCV RESPOND 2 60 PFO migraine 60 LymphoStat B belimumab 60 ACOMPLIA R 60 Inc. Nasdaq VVUS 60 aclidinium bromide 60 vaginally administered lidocaine 60 Successfully Completes Phase 60 Cloretazine ® 60 Allovectin 7 ® 60 Solasia 60 evaluating Actimmune 60 Multiple Ascending Dose 60 Phase III placebo controlled 60 Regeneron Pharma 60 albiglutide 60 Onyx Pharma 60 XIENCE V Stent System 60 IL# PE#QQR 60 Fx #A 60 Nasdaq VRTX 60 Asentar 60 Alexis Borisy President 60 ALN VSP Phase 60 Luveniq 60 zileuton CR 60 bosutinib 60 antibody MAb 60 randomized Phase IIb 60 PRE SURGE 60 WILEX 60 TG MV 60 blinded randomized placebo controlled 60 dextromethorphan quinidine 60 OvaRex ® MAb 60 CAPACITY trials 60 doxorubicin Transdrug ® 60 thetreatment 60 Phase III clinical trials 60 Phase III Clinical Trial 60 OncoVEX 60 Phenoptin 60 Panzem R 60 multiple ascending dose 60 Tesmilifene 60 OvaRex R 60 Nasdaq ACOR 60 Phase 2b 60 EMPOWER ™ 60 docetaxel Taxotere R 60 Pruvel 60 OMNARIS HFA 60 IGXT IntelGenx today 60 SNT-MC#/idebenone 60 FDA Approvable Letter 60 R#/MEM # 60 corticotropin injection 60 PRIMO CABG 60 Oncoscience AG 60 APPRAISE 60 StemEx R 60 sterile lidocaine patch 60 successfully commercialize Iluvien 60 generation purine nucleoside 60 confirmatory clinical 60 hypoxia activated prodrug 60 diabetic neuropathic pain 60 Flutiform ™ 60 PDX pralatrexate 60 Phase III ALLEGRO 60 CIP TRAMADOL ER 60 Combination REOLYSIN R 60 ACTEMRA TM 60 Phase IIa clinical trials 60 NASDAQ SCLN 59 ThermoDox ® clinical 59 IND enabling 59 inhaled AAT 59 volociximab 59 GED aPC 59 Nexavar sorafenib 59 formal pharmacokinetic PK 59 Nasdaq PGNX today 59 evaluating REVLIMID 59 multicenter randomized Phase 59 ularitide 59 Orathecin 59 NASDAQ FLML 59 Tovaxin TM 59 Phase IIb Trial 59 NYSE Amex PBTH 59 Zensana TM 59 Myocet 59 RANK Ligand inhibitor 59 Initiates Clinical 59 bicifadine 59 Zerenex ™ 59 Initiates Phase 2b 59 LO LOESTRIN FE 59 BioSante LibiGel Phase III 59 CR# vcMMAE 59 CONBRIZA 59 Nuvion 59 vosaroxin 59 visilizumab 59 NVA# 59 L BLP# 59 Ascend Therapeutics 59 Xcytrin R 59 comparing alemtuzumab 59 velafermin 59 Vectibix panitumumab 59 Anturol TM 59 XL# anticancer compounds 59 Tykerb lapatinib 59 AMD# [002] 59 OLEPTRO 59 BLOOM DM 59 inhaled liposomal ciprofloxacin 59 Pimavanserin 59 generation URAT1 inhibitor 59 Phase #/#a 59 opioid induced bowel dysfunction 59 Alvesco R 59 Neo Kidney Augment 59 Evoltra 59 Panzem ® 59 sNDA submission 59 evaluating RDEA# 59 Phase III metastatic melanoma 59 NP2 Enkephalin 59 LibiGel ® testosterone gel 59 REG2 59 severe hypercholesterolemia 59 Phase IIA 59 Bioral Amphotericin B 59 evaluating bafetinib 59 PTK ZK 59 Inc. OTCBB SYBD 59 trodusquemine 59 Phase Ib clinical trials 59 lorvotuzumab mertansine 59 Marketing Authorization Application MAA 59 Acetavance 59 NASDAQ PCYC 59 Inc. NASDAQ BPAX 59 Circ Pharma 59 incyclinide 59 oncolytic virus therapies 59 Tarceva TM 59 omacetaxine mepesuccinate 59 initiated Phase 1b 59 Nasdaq ONXX today 59 fund BioSante LibiGel 59 Pirfenidone 59 Firazyr 59 BRIM3 59 NDA submission 59 GSK# [002] 59 Evoltra ® 59 ocrelizumab 59 sunitinib malate 59 GENR 59 ALN PCS 59 TASKi2 59 HCD# [002] 59 personalized cellular immunotherapy 59 Efficacy Results 59 trastuzumab emtansine T DM1 59 Relovair 59 Marketing Authorisation Application 59 Submits Response 59 LibiGel testosterone gel 59 teduglutide 59 Ostarine 59 methylnaltrexone bromide 59 Hedgehog antagonist 59 Levoleucovorin 59 Daclizumab 59 PROVENGE ® 59 malignant mesothelioma Alfacell 59 VALOR trial 59 generation rotary VAD 59 TransVax TM 59 randomized controlled multicenter 59 Glufosfamide 59 Targretin capsules 59 rotary VAD 59 APEX AMI trial 59 Camvia 59 BLA submission 59 vaccine GMK 59 LE SN# 59 viral kinetic 59 Dextofisopam 59 HuMax EGFr 59 PrevOnco ™ 59 investigational HCV polymerase 59 MAP Pharma 59 PD LID 59 Preos 59 telomerase inhibitor drug 59 CDP# 59 histone deacetylase HDAC inhibitor 59 TELINTRA R 59 application sNDA 59 REMUNE R 59 Pivotal Phase 59 fidaxomicin Phase 3 59 fostamatinib 59 OncoVEX GM CSF 59 Nasdaq OPTR 59 FACTIVE R gemifloxacin 59 Therapeutic Competitors companiesandmarkets.com adEgemonye 59 toenail onychomycosis 59 methylphenidate transdermal system 59 submit Biologics License 58 OvaRex 58 Benlysta belimumab 58 Loramyc ™ 58 Aryplase 58 dextofisopam 58 GRN# 58 multicenter randomized placebo controlled 58 palifosfamide Zymafos TM 58 atacicept 58 Canvaxin TM 58 Tracleer r 58 Exherin TM 58 TOCOSOL Camptothecin 58 Voraxaze 58 Cimzia ® certolizumab pegol 58 Testosterone MDTS ® 58 GVAX R 58 Lenocta TM 58 Ketotransdel 58 PNP inhibitor 58 PI3K/Akt pathway inhibitor 58 including eniluracil ADH 58 candidate AQ4N 58 huC# DM4 58 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 58 maximally tolerated dose 58 NSABP C 58 initiated confirmatory Phase 58 Amigal TM 58 zanolimumab 58 subcutaneous formulation 58 Ziopharm 58 Safinamide 58 pain palliation 58 Onrigin 58 AEG# 58 ARISE Phase III 58 resminostat 58 CTAP# Capsules 58 AKT inhibitor 58 Phase #b/#a trial 58 BiTE R 58 PRT# 58 confirmatory Phase 58 nonclinical studies 58 transmucosal delivery system 58 ponatinib 58 Empatic TM 58 Febuxostat 58 ELACYT 58 Adventrx 58 hoFH 58 budiodarone 58 miconazole Lauriad ® 58 Lupuzor 58 Clolar ® 58 FlutiformTM 58 Amrubicin 58 PA# [002] 58 CUSTOM III 58 Crofelemer budesonide foam 58 RhuDex 58 Gentamicin Surgical Implant 58 Biologics License Application BLA 58 IIa clinical trials 58 Phase 2b Clinical Trial 58 telomerase therapeutic 58 SMT C# 58 sumatriptan DosePro 58 European Sepsis Trial 58 tanespimycin 58 Evoltra R 58 Silodosin 58 maribavir 58 randomized controlled Phase 58 Genz # 58 GENASIS 58 PREOS 58 Nexavar ® 58 EnzymeRx 58 Prosaptide 58 allosteric modulator PAM 58 Darusentan 58 Meets Primary Endpoint 58 Advaxis Phase 58 Loramyc 58 RH1 58 Phase IIIb study 58 HQK 58 labial herpes 58 GOUT 58 HDL Mimetic Peptide 58 Triapine R 58 CoFactor 58 MKC# MT 58 lumiliximab 58 OPT CHF 58 Augment Injectable 58 investigational antiplatelet agent 58 novel VDA molecule 58 THALOMID 58 Inc. NASDAQ ORXE 58 investigational therapies 58 IIa clinical trial 58 romidepsin 58 Civacir 58 CCR9 antagonist 58 Urocortin 2 58 Phase 1b dose escalation 58 phase III isavuconazole 58 Shigamabs R 58 Deferiprone 58 NasdaqGM NTEC today 58 Omnitarg 58 Initiate Phase II 58 SPL# Gel vaginal microbicide 58 TMC# C# 58 R# #mg BID 58 LBH# 58 placebo controlled Phase 58 Phase III TRIST 58 Chemophase 58 Loramyc R 58 NABTT 58 Intermezzo ® NDA 58 MIST II 58 PROMUS Element Stent System 58 Veronate 58 NASDAQ NPSP 58 Ambrisentan 58 RhuDex ® 58 Hedgehog Pathway Inhibitor 58 lexidronam injection 58 Inc. NASDAQ IDIX 58 Tyzeka Sebivo 58 ORAL Sync 58 PHASE III 58 novel oral anticoagulant 58 ASX PGL 58 anticancer compound 58 Hsp# Inhibitor 58 MoxDuo IR 58 assessing T DM1 58 brentuximab 58 unblind 58 ridaforolimus 58 Zavesca r 58 phase IIIb 58 Achieves Primary Endpoint 58 DEB# 58 beta 1a 58 TELINTRA 58 Phase III confirmatory 58 lurasidone 58 Arzerra ofatumumab 58 Oncotype DX colon cancer 58 TRACON Pharmaceuticals 58 Nasdaq DVAX 58 SNT MC# 58 teriflunomide 58 NASDAQ REGN 58 Capesaris 58 PLK1 SNALP 58 Vitaxin 58 Onconase 58 Nasdaq MAPP 58 telaprevir VX 58 Cleviprex TM clevidipine 58 Inc. Nasdaq ACOR 58 LUX Lung 58 samalizumab 58 includes TOLAMBA TM 58 Aroplatin 58 Orqis Medical 58 MOVIPREP R 58 RELOVAIR ™ 58 Varespladib 58 ZACTIMA 58 Somatuline R Autogel R 58 Reverset 58 clevudine 58 Nasdaq CYCC Nasdaq CYCCP 58 Fenoglide 58 GVAX ® 58 eritoran 58 fidaxomicin Phase 57 glufosfamide 57 motesanib 57 Factor VIIa 57 relapsing remitting MS RRMS 57 UCB Cimzia 57 EFAPROXYN 57 pertuzumab 57 novel therapeutic antibodies 57 LibiGel Phase III 57 refractory chronic lymphocytic 57 PRTX 57 include Ischemic Paraplegia 57 Initiate Clinical Trial 57 Presents Positive 57 candidates Dyloject TM 57 Georges Gemayel 57 NASDAQ CXSP announced 57 dexanabinol 57 REMINYL ® 57 XL# XL# XL# XL# 57 Phase 2a Trial 57 ZEGERID Capsules 57 SAR# [004] 57 LidoPAIN SP 57 EchoCRT 57 Aurora kinase inhibitor 57 OTCBB UGNE http:/www.unigene.com 57 CEQ# 57 randomized multicenter Phase III 57 placebo controlled Phase III 57 Trofex TM 57 vinorelbine tartrate 57 MERLIN TIMI 57 Acapodene 57 Phase III trials 57 MKC# MKC# PP 57 Vertex Pharma 57 Ron Bentsur 57 Somatuline R Depot 57 urocortin 2 57 Phase III Trial 57 CLIRS 57 Phase III registrational 57 NYSE Amex HEB 57 SYCREST 57 DDP# 57 Mr. Kriegsman 57 ATryn R 57 SinuNase 57 Teplizumab 57 PMA submission 57 PEARL HF 57 Tarvacin Anti Cancer 57 Somatuline Depot 57 oxypurinol 57 KNS # 57 PRX # 57 Ceplene histamine dihydrochloride 57 PRIMO CABG2 57 metastatic castration resistant 57 II Clinical Trial 57 Steven R. Deitcher 57 APF# NDA 57 MGd 57 QRxPharma 57 ANCHOR trial 57 3 registrational trial 57 drug pipeline TAFA# 57 Nasdaq BCRX 57 IV APAP 57 ZALBIN 57 adjuvant GIST 57 Hyphanox 57 cutaneous T 57 mesylate tablets 57 Frova ® 57 Phase IIB clinical 57 Hepatitis C HCV 57 CD# CEA 57 P#X# antagonist 57 axitinib 57 TBC M4 57 histamine dihydrochloride 57 tezampanel NGX# 57 Safi Bahcall Ph.D. 57 APTIVUS 57 drug figitumumab 57 Æterna Zentaris 57 QNEXA 57 Matrix Phase 2b 57 EGS# 57 Raptiva efalizumab 57 Immunotherapeutic 57 ThermoDox R 57 DIFICID ™ 57 PXD# 57 generation proteasome inhibitor 57 Soliris TM eculizumab 57 Laquinimod 57 prostate cancer antigen prostatic 57 HCV SPRINT 57 Submits NDA 57 TASKi3 57 eniluracil 57 YONDELIS R 57 Nasdaq GPCB 57 denosumab oncology 57 Inc. NASDAQ SNUS 57 LEVADEX TM 57 Inc. NASDAQ NBIX 57 miconazole Lauriad R 57 Commence Phase 57 IMiD 57 Commences Phase 57 LibiGel ® 57 Initiated Phase 57 TACI Ig 57 ostarine 57 Inc. Nasdaq CRTX 57 edoxaban 57 BCR ABL inhibitor 57 tremelimumab 57 degeneration gastrointestinal disorders 57 NeuVax 57 Neuvenge 57 ORENCIA ® 57 dalbavancin 57 AAG geldanamycin analog 57 ZYBRESTAT fosbretabulin 57 Phase IIa proof 57 huN# DM1 57 BENLYSTA ® 57 preclinical pharmacokinetic 57 single ascending dose 57 Marqibo 57 Genasense ® oblimersen 57 Qutenza TM 57 indiplon capsules 57 Dermylex TM 57 TransVax 57 Deforolimus 57 ketoprofen patch 57 leading oral taxane 57 Firdapse 57 Perforomist TM formoterol fumarate 57 follicular Non Hodgkin 57 REG1 Anticoagulation System 57 AMITIZA R 57 Humira adalimumab 57 clinical pharmacology studies 57 Mr. Armando Anido 57 Inc. Nasdaq SEPR 57 custirsen 57 NASDAQ IDEV 57 Telik logo TELINTRA 57 Amoxicillin PULSYS 57 ospemifene 57 thorough QT 57 THR beta agonist 57 ICA # 57 riociguat 57 Dr. Scangos 57 apoptosis inducer 57 BR.# 57 Cethrin R 57 dose cohort 57 bepotastine besilate nasal spray 57 refractory acute lymphoblastic 57 OLEPTRO TM 57 ABSORB clinical 57 eltrombopag 57 CRD5 57 OFIRMEV 57 apricitabine 57 Trobalt 57 Cetrorelix 57 Premarket Approval Application 57 topical agent Xantryl 57 EndoTAG TM -1 57 Ultrafast Insulin 57 Zerenex 57 PRESEPT 57 macitentan 57 EVIZON TM squalamine lactate 57 R sorafenib tablets 57 AMEX DDD 57 developing ostarine selective 57 Traficet EN 57 Inc. NASDAQ HITK 57 MAXY alpha 57 SILENOR ™ 57 NASDAQ ACOR 57 MEK inhibitor 57 novel trazodone formulation 57 Clavis Pharma 57 RIGScan CR 57 Zemiva TM 57 opioid bowel dysfunction 57 Insmed Incorporated NASDAQ INSM 57 E2F Decoy 57 Trofex 57 DAYTRANA TM 57 Polymeropoulos 57 AQ4N 57 LibiGel BioSante 57 gepirone ER 57 sitaxsentan sodium 57 ProSavin 57 Nasdaq NYMX 57 Oncogenex 57 ZADAXIN ® 57 ALN TTR 57 Vicriviroc 57 commercialize toremifene 57 PROSTVAC ® 57 UPLYSO 57 EXPAREL ™ 57 orBec 57 treatment naïve genotype 57 CLARITY study 57 Phase IIb Clinical Trial 57 CBLC# 57 Lixivaptan 57 isavuconazole 57 CG# [003] 57 Gendux 57 BEMA TM LA 57 Alnylam Nasdaq ALNY 57 Inc. NASDAQ ALTH 57 NEBIDO R 57 apaziquone 57 HCl Tablets 57 GLPG# 57 sNDA filing 57 Clonicel 57 AMPAKINE CX# 57 HDL Selective Delipidation 57 Marketing Authorisation Application MAA 57 orally inhaled migraine 57 INTEGRILIN R eptifibatide Injection 57 rhIGF-I/rhIGFBP-3 57 OMAPRO ™ 57 Keppra ® XR 57 RhuDex R 57 Steve Worland Ph.D. 57 TRISENOX 57 vernakalant oral 57 Hacksell 57 refractory APL 57 ARRY # 57 Triapine 57 selective immunoproteasome inhibitor 57 postoperative ileus POI 57 Oleptro 56 Mihael Polymeropoulos MD 56 Pivotal Clinical Trial 56 SCHWARZ PHARMA 56 Approvable letter 56 Xeloda ® 56 Avastin adjuvant 56 BioMarin Pharma 56 Testosterone MDTS R 56 Prodarsan 56 Plenaxis TM 56 bavituximab monotherapy trial 56 enoximone capsules 56 sapacitabine CYC# 56 R roscovitine 56 PS# DARA 56 Inc. Nasdaq IMGN 56 Qnexa TM 56 adecatumumab 56 HP Acthar Gel repository 56 SILENOR 56 StaphVAX R 56 Spiegelmer ® 56 proprietary intravenous formulation 56 Neupro R 56 SWX SPPN 56 BIM #A# 56 Cintredekin Besudotox 56 Elagolix 56 Study #CL# 56 Toremifene 56 TKB# 56 CytoFabTM 56 Nasdaq MITI biopharmaceutical 56 BioDelivery Sciences Announces 56 diarrhea predominant irritable 56 mg/m2 cohort 56 Lovaxin C 56 NASDAQ ABII 56 XL# SAR# 56 IND CTA 56 PROGENSA R 56 Intarcia